Acute central nervous system graft-versus-host-disease after liver transplantation

2021 ◽  
pp. 101521
Author(s):  
Valérie Massey ◽  
Véronique Martel ◽  
Dang Khoa Nguyen ◽  
Lambert Busque ◽  
Hugo Chapdelaine ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Liver Transplantation ◽  
Nervous System ◽  
Graft Versus Host Disease ◽  
Host Disease ◽  
Graft Versus Host

scholarly journals Possible graft-versus-host disease involving the central nervous system soon after cord blood transplantation

2009 ◽  
Vol 84 (11) ◽  
pp. 764-766 ◽  
Author(s):  
Hisashi Yamamoto ◽  
Naoyuki Uchida ◽  
Kazuya Ishiwata ◽  
Hideki Araoka ◽  
Shinsuke Takagi ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Cord Blood ◽  
Graft Versus Host Disease ◽  
Cord Blood Transplantation ◽  
Host Disease ◽  
Graft Versus Host ◽  
Blood Transplantation ◽  
The Central Nervous System

Graft-versus-Host Disease in the Central Nervous System: A Real Entity?

1988 ◽  
Vol 89 (4) ◽  
pp. 543-546 ◽  
Author(s):  
Emilie Rouah ◽  
Regina Gruber ◽  
William Shearer ◽  
Dawna Armstrong ◽  
Edith P. Hawkins
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Graft Versus Host Disease ◽  
Host Disease ◽  
Graft Versus Host ◽  
System A ◽  
The Central Nervous System ◽  
Real Entity

scholarly journals Successful treatment with fingolimod of graft-versus-host disease of the central nervous system

2018 ◽  
Vol 2 (1) ◽  
pp. 10-13 ◽  
Author(s):  
Jordan Gauthier ◽  
Patrick Vermersch ◽  
Paul Chauvet ◽  
Pauline Varlet ◽  
Valérie Coiteux ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Graft Versus Host Disease ◽  
Successful Treatment ◽  
Host Disease ◽  
Graft Versus Host ◽  
Receptor Agonists ◽  
Key Points ◽  
Sphingosine 1 Phosphate ◽  
The Central Nervous System

Key Points Fingolimod could be efficient to treat GVHD of the central nervous system. Further research should explore the use of fingolimod and other sphingosine-1-phosphate receptor agonists to prevent or treat GVHD.

scholarly journals Central nervous system graft-versus-host disease in a 68-year-old man presenting with myoclonus

2019 ◽  
Vol 191 (39) ◽  
pp. E1078-E1081
Author(s):  
Xin Wang ◽  
Maxime Billick ◽  
Danny Monsour ◽  
Jessica Liu
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Graft Versus Host Disease ◽  
Host Disease ◽  
Graft Versus Host

scholarly journals A Case Report of Central Nervous System Graft-Versus-Host Disease and Literature Review

2021 ◽  
Vol 12 ◽  
Author(s):  
Mingming Li ◽  
Yue Zhang ◽  
Yujia Guan ◽  
Zunwei Zhang ◽  
Hanbing Dong ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Graft Versus Host Disease ◽  
Clinical Manifestations ◽  
Fatal Disease ◽  
Hematopoietic Stem ◽  
Host Disease ◽  
Graft Versus Host ◽  
Diffuse White Matter ◽  
The Central Nervous System

As an adverse immune phenomenon, graft-versus-host disease often occurs after allogeneic hematopoietic stem cell transplantation. The incidence of acute and chronic graft-versus-host disease is about 40–60% and the mortality rate can reach 15%, which is a potentially fatal disease. There are rare GvHD cases involving the central nervous system. We reported a rare case of diffuse white matter changes after haploid bone marrow transplantation, summarizing its clinical manifestations and diagnosis and treatment in conjunction with the literature.

Sign in / Sign up

Export Citation Format

Share Document